The Infection Control market is estimated 25 billion by 2025 growing at a CAGR of 6.0 % from 2018-2025. Factors like increasing prevalence of hospital acquired infections, elevating count of surgical procedures, strict safety norms and regulations, and technical advancements in sterilization processes search to be the driving factors of this market. However, sterilization of advanced medical instruments and increasing concern related to safety of reprocessed instruments hamper the growth of this market.
Additionally, high adoption rate of E-beam sterilization and merger of pharmaceutical and medical device manufacturer are also boosting the growth of the infection control market, globally. Moreover, the non-compliance issues by the end users with respect to the sterilization standards is the prime challenging factor for this market. The infection control market is segmented on the basis of products & services, end user and geography.
On the basis of products & services, the market is further fragmented into sterilization products and services, disinfectants, medical non-woven and disinfector. Among all, the disinfection segment holds the largest market share, owing to the growing application of infection control systems in hospitals, the growing need for reduction of cross contamination in food and Pharmaceutical sectors and the high adaptability rate of skin and hand disinfectants.
Additionally, the infection control market is also segmented on the basis of end-user, as hospitals, medical device companies, pharmaceutical companies, life science industry, clinical laboratories, food industry and others. Hospital segment dominates this market, accounting to the increasing prevalence of hospital acquired infections, elevating health related expenditures due to the increasing count of elderly population and chronic diseases. Moreover, the threat of infectious diseases like AIDS, Ebola and antivirus in the last 3 decades is also responsible in fueling the growth of the market.
On the basis of geography, North America dominates this market, followed by Europe, Asia and ROW. The increasing demand for infection control products, growing awareness about hygiene and infection free environment coupled with increasing count of surgical processes also plays an important role in propelling the growth of infection control market in North America. In addition, the supportive government policies, changing lifestyles and growing geriatric population further increases the demand for infection control systems.
Asian region is also expected to have a study growth during the forecast years, accounting to the growing economies of developing countries like India and China, increasing prevalence of nosocomial infections coupled with the improvement and expansion of healthcare infrastructure of this region. However, the growing outsourcing trend by the established key players of developed regions to the company's present in Asian regions is also responsible in boosting the growth of infection control market.
The key players operating in this industry are 3M Company, Ahlstrom Corporation, Belimed AG, Cisa S.p.A, Getinge Group, Honeywell International, Inc., Johnson & Johnson Limited, Kimberly-Clark Corporation, Matachana Group, Nordion Inc., Sakura Global Holding Company Ltd., Sterigenics International, Inc., STERIS Corporation, Synergy Health plc, and TSO3 Inc.
1 Introduction
1.1 Goal & Objective
1.2 Report Coverage
1.3 Supply Side Data Modelling & Methodology
1.4 Demand Side Data Modelling & Methodology
2 Executive Summary
3 Market Outlook
3.1 Introduction
3.2 Current & Future Outlook
3.3 DROC
3.3.1 Drivers
3.3.1.1 Demand Drivers
3.3.1.2 Supply Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.3.4 Challenges
3.4 Market Entry Matrix
3.5 Market Opportunity Analysis
3.6 Market Regulations
3.7 Pricing Mix
3.9 Value Chain & Ecosystem
3.8 Key Customers
4 Supply Side Analysis
4.1 Sterlization Products & Services
4.1.1 Sterlisation Equipments
4.1.1.1 Low Temperature Sterlization
4.1.1.2 Heat Sterlization Equipment
4.1.1.3 Flitration Sterlization Equipment
4.1.1.4 Radiation Sterlization Equipment
4.2.1 Contract Sterilization Services Market, By Type
4.2.1.1 Ethylene Oxide Sterilization Services
4.2.1.2 Gamma Sterilization Services
4.2.1.3 E-Beam Sterilization Services
4.2.1.4 Others
4.3.1 Consumables & Accessories
4.3.1.1 Sterilant Cassettes
4.3.1.2 Sterlization Indicators
4.3.1.3 Others
4.2 Disinfectants
4.2.1 Disinfectants Market, By Sub- Type
4.2.1.1 Skin Disinfectants
4.2.1.1.1 By Formulations
4.2.1.1.1.1
4.2.1.1.1.2
4.2.1.1.1.3
4.2.1.2 Hand Disinfectants
4.2.1.2.1 By Formulations
4.2.1.2.1.1
4.2.1.2.1.2
4.2.1.2.1.3
4.2.1.3 Surface Disinfectants
4.2.1.3.1 By Formulations
4.2.1.3.1.1
4.2.1.3.1.2
4.2.1.3.1.3
4.2.1.4 Instruments Infectants
4.2.1.4.1 By Formulations
4.2.1.4.1.1
4.2.1.4.1.2
4.2.1.4.1.3
4.2.2 By EPA Classification
4.2.2.1 Low-Level Disinfectants
4.2.2.1.1 QUATS
4.2.2.2 Intermediate-Level Disinfectants
4.2.2.2.1 Chlorine compounds
4.2.2.2.2 Alcohols
4.2.2.3 High-Level Disinfectants
4.2.2.3.1 Oxidising Agents
4.2.2.3.2 Aldehydes
4.2.2.3.3 Others
4.3 Medical Nonwovens
4.3.1 Surgical Drapes
4.3.2 Surgical Gowns
4.3.3 Sterilization Wraps
4.3.4 Face Masks
4.4 Disinfectors
4.4.1 Washer Disinfectors
4.4.1.1 Single Chamber
4.4.1.2 Multi Chamber
4.4.1.3 Flusher Disinfectors
4.4.1.4 UV Ray Disinfectors
4.4.2 Endoscope Reprocessors
5 Infection Control Market, By End-User
5.1 Introduction
5.2 Hospitals
5.3 Medical Device Companies
5.4 Pharmaceutical Companies
5.5 Life Sciences Industry
5.6 Clinical Laboratories
5.7 Food Industry
5.8 Others
6 Infection Control Market Analysis, By Region
6.1 North America
6.1.1 U.S.
6.1.2 Canada
6.1.3 Mexico
6.2 Europe
6.2.1 Germany
6.2.2 Italy
6.2.3 France
6.2.4 UK
6.2.5 Belgium
6.2.6 Rest of Europe
6.3 Asia Pacific
6.3.1 China
6.3.2 Japan
6.3.3 India
6.3.4 Australia
6.3.5 Rest of APAC
6.4 Middle East & Africa
6.4.1 Saudi Arabia
6.4.2 UAE
6.4.3 Rest Of MEA
6.5 South America
6.5.1 Brazil
6.5.2 Argentina
6.5.3 Rest of South America
7 Supply Side Analysis
7.1 Strategic Benchmarking
7.2 Market Share Analysis
7.3 Key Players
7.3.1 3M Company
7.3.2 Halyard Health, Inc.
7.3.3 Getinge Group
7.3.4 Advanced Sterilization Products (A Johnson & Johnson Company)
7.3.5 Matachana Group & Others
7.3.6 Belimed AG
7.3.7 MMM Group
7.3.8 Cantel Medical Corporation
7.3.9 Steris Corporation
7.3.10 Sterigenics International, Inc.
7.3.11 Ecolab
7.3.12 Reckitt Benckiser
7.3.13 Metrex Research & Others
SDMR employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach
Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.
Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis
Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price
Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image
